We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy
Thymosin for injection is mainly used in the treatment of various primary or secondary T cell defect diseases, some autoimmune diseases, low cell function and other diseases and adjuvant therapy of tumors, and its clinical use is mostly intravenous drip. The osmotic pressure of injection is an important parameter to evaluate the safety of injection. In the course of clinical use, the osmotic pressure of the injection should be adjusted to the tolerable range of the human body, otherwise it will cause the deformation of the body's red blood cells or even rupture and hemolysis, or stimulate the local tissue cells and cause pain.
We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy